These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


573 related items for PubMed ID: 20638987

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
    Takano M, Otsuka F, Matsumoto Y, Inagaki K, Takeda M, Nakamura E, Tsukamoto N, Miyoshi T, Sada KE, Makino H.
    Mol Cell Endocrinol; 2012 Jan 02; 348(1):224-32. PubMed ID: 21888945
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling.
    Matsumoto Y, Otsuka F, Hino J, Miyoshi T, Takano M, Miyazato M, Makino H, Kangawa K.
    Mol Cell Endocrinol; 2012 Mar 05; 350(1):78-86. PubMed ID: 22155034
    [Abstract] [Full Text] [Related]

  • 7. Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2.
    Katsuyama T, Otsuka F, Terasaka T, Inagaki K, Takano-Narazaki M, Matsumoto Y, Sada KE, Makino H.
    Peptides; 2015 Nov 05; 73():88-94. PubMed ID: 26409788
    [Abstract] [Full Text] [Related]

  • 8. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
    Luppen CA, Smith E, Spevak L, Boskey AL, Frenkel B.
    J Bone Miner Res; 2003 Jul 05; 18(7):1186-97. PubMed ID: 12854828
    [Abstract] [Full Text] [Related]

  • 9. Epinephrine accelerates osteoblastic differentiation by enhancing bone morphogenetic protein signaling through a cAMP/protein kinase A signaling pathway.
    Uemura T, Ohta Y, Nakao Y, Manaka T, Nakamura H, Takaoka K.
    Bone; 2010 Oct 05; 47(4):756-65. PubMed ID: 20637325
    [Abstract] [Full Text] [Related]

  • 10. Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts.
    Viereck V, Siggelkow H, Tauber S, Raddatz D, Schutze N, Hüfner M.
    J Cell Biochem; 2002 Oct 05; 86(2):348-56. PubMed ID: 12112004
    [Abstract] [Full Text] [Related]

  • 11. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
    Jørgensen NR, Henriksen Z, Sørensen OH, Civitelli R.
    Steroids; 2004 Apr 05; 69(4):219-26. PubMed ID: 15183687
    [Abstract] [Full Text] [Related]

  • 12. Estrogen receptor-beta modulates synthesis of bone matrix proteins in human osteoblast-like MG63 cells.
    Cao L, Bu R, Oakley JI, Kalla SE, Blair HC.
    J Cell Biochem; 2003 May 01; 89(1):152-64. PubMed ID: 12682916
    [Abstract] [Full Text] [Related]

  • 13. The role of noggin in human mesenchymal stem cell differentiation.
    Rifas L.
    J Cell Biochem; 2007 Mar 01; 100(4):824-34. PubMed ID: 17133353
    [Abstract] [Full Text] [Related]

  • 14. Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells.
    Tanaka K, Inoue Y, Hendy GN, Canaff L, Katagiri T, Kitazawa R, Komori T, Sugimoto T, Seino S, Kaji H.
    Bone; 2012 Jul 01; 51(1):158-67. PubMed ID: 22579779
    [Abstract] [Full Text] [Related]

  • 15. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
    Yonezawa T, Lee JW, Hibino A, Asai M, Hojo H, Cha BY, Teruya T, Nagai K, Chung UI, Yagasaki K, Woo JT.
    Biochem Biophys Res Commun; 2011 Jun 03; 409(2):260-5. PubMed ID: 21570953
    [Abstract] [Full Text] [Related]

  • 16. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A, Ly C, Cipetić M, Sims NA, Vieusseux J, Kartsogiannis V, Bouralexis S, Saleh H, Zhou H, Price JT, Martin TJ, Ng KW, Gillespie MT, Quinn JM.
    Bone; 2007 Feb 03; 40(2):305-15. PubMed ID: 17049328
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dexamethasone modulates BMP-2 effects on mesenchymal stem cells in vitro.
    Jäger M, Fischer J, Dohrn W, Li X, Ayers DC, Czibere A, Prall WC, Lensing-Höhn S, Krauspe R.
    J Orthop Res; 2008 Nov 03; 26(11):1440-8. PubMed ID: 18404732
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.